Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement November 17, 2021
Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors November 4, 2021
